Global Classical Swine Fever Vaccines Market Research Report 2023

Global Classical Swine Fever Vaccines Market Research Report 2023

Table of Contents
1 Classical Swine Fever Vaccines Market Overview 1
1.1 Product Definition 1
1.2 Classical Swine Fever Vaccines by Source 1
1.2.1 Global Classical Swine Fever Vaccines Market Value Comparison by Source (2023-2029) 2
1.2.2 Tissue Culture Origin 3
1.2.3 Cell Line Origin 4
1.3 Classical Swine Fever Vaccines by Sales Channel 5
1.3.1 Global Classical Swine Fever Vaccines Market Value by Sales Channel (2023-2029) 5
1.3.2 Government Tender 7
1.3.3 Market Sales 8
1.4 Global Classical Swine Fever Vaccines Market Size Estimates and Forecasts 8
1.4.1 Global Classical Swine Fever Vaccines Revenue 2018-2029 8
1.4.2 Global Classical Swine Fever Vaccines Sales 2018-2029 10
1.4.3 Global Classical Swine Fever Vaccines Market Average Price (2018-2029) 11
1.5 Assumptions and Limitations 11
2 Classical Swine Fever Vaccines Market Competition by Manufacturers 14
2.1 Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2018-2023) 14
2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2019-2023) 17
2.3 Global Classical Swine Fever Vaccines Average Price by Manufacturers (2019-2023) 20
2.4 Global Key Players of Classical Swine Fever Vaccines, Industry Ranking, 2021 VS 2022 22
2.5 Global Key Manufacturers of Classical Swine Fever Vaccines, Area Served & Headquarters 23
2.6 Global Key Manufacturers of Classical Swine Fever Vaccines, Product Type & Application 24
2.7 Founded Data of Global Key Classical Swine Fever Vaccines Manufacturers 25
2.8 Global Classical Swine Fever Vaccines Market Competitive Situation and Trends 26
2.8.1 Global Classical Swine Fever Vaccines Market Concentration Rate 26
2.8.2 The Global 5 and 10 Largest Classical Swine Fever Vaccines Players Market Share by Revenue 27
2.8.3 Global Classical Swine Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) 28
3 Global Classical Swine Fever Vaccines Market Scenario by Region 30
3.1 Global Classical Swine Fever Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029 30
3.2 Global Classical Swine Fever Vaccines Sales by Region: 2018-2029 31
3.2.1 Global Classical Swine Fever Vaccines Sales by Region: 2018-2023 31
3.2.2 Global Classical Swine Fever Vaccines Sales by Region: 2024-2029 32
3.3 Global Classical Swine Fever Vaccines Revenue by Region: 2018-2029 33
3.3.1 Global Classical Swine Fever Vaccines Revenue by Region: 2018-2023 33
3.3.2 Global Classical Swine Fever Vaccines Revenue by Region: 2024-2029 33
3.4 North America Classical Swine Fever Vaccines Market Facts & Figures by Country 34
3.4.1 North America Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 34
3.4.2 North America Classical Swine Fever Vaccines Sales by Country (2018-2029) 35
3.4.3 North America Classical Swine Fever Vaccines Revenue by Country (2018-2029) 36
3.4.4 U.S. 38
3.4.5 Canada 38
3.4.6 Mexico 39
3.5 Europe Classical Swine Fever Vaccines Market Facts & Figures by Country 39
3.5.1 Europe Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 39
3.5.2 Europe Classical Swine Fever Vaccines Sales by Country (2018-2029) 40
3.5.3 Europe Classical Swine Fever Vaccines Revenue by Country (2018-2029) 41
3.5.4 Germany 43
3.5.5 France 43
3.5.6 U.K. 44
3.5.7 Italy 44
3.5.8 Russia 45
3.6 Asia Pacific Classical Swine Fever Vaccines Market Facts & Figures by Region 45
3.6.1 Asia Pacific Classical Swine Fever Vaccines Market Size by Region: 2018 VS 2022 VS 2029 45
3.6.2 Asia Pacific Classical Swine Fever Vaccines Sales by Region (2018-2029) 46
3.6.3 Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2018-2029) 47
3.6.4 China 49
3.6.5 Japan 49
3.6.6 South Korea 50
3.6.7 India 50
3.6.8 Australia 51
3.6.9 Southeast Asia 51
3.7 South America Classical Swine Fever Vaccines Market Facts & Figures by Country 52
3.7.1 South America Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 52
3.7.2 South America Classical Swine Fever Vaccines Sales by Country (2018-2029) 52
3.7.3 South America Classical Swine Fever Vaccines Revenue by Country 53
3.7.4 Brazil 54
3.8 Middle East and Africa Classical Swine Fever Vaccines Market Facts & Figures by Country 54
3.8.1 Middle East and Africa Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 54
3.8.2 Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2018-2029) 55
3.8.3 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country 56
3.8.4 Middle East 57
3.8.5 Africa 58
4 Segment by Source 59
4.1 Global Classical Swine Fever Vaccines Sales by Source (2018-2029) 59
4.1.1 Global Classical Swine Fever Vaccines Sales by Source (2018-2023) 59
4.1.2 Global Classical Swine Fever Vaccines Sales by Source (2024-2029) 59
4.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Source (2018-2029) 59
4.2 Global Classical Swine Fever Vaccines Revenue by Source (2018-2029) 61
4.2.1 Global Classical Swine Fever Vaccines Revenue by Source (2018-2023) 61
4.2.2 Global Classical Swine Fever Vaccines Revenue by Source (2024-2029) 61
4.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2018-2029) 61
4.3 Global Classical Swine Fever Vaccines Price by Source (2018-2029) 62
5 Segment by Sales Channel 64
5.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2029) 64
5.1.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) 64
5.1.2 Global Classical Swine Fever Vaccines Sales by Sales Channel (2024-2029) 64
5.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2018-2029) 64
5.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2018-2029) 66
5.2.1 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2018-2023) 66
5.2.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2024-2029) 66
5.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2018-2029) 66
5.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2018-2029) 68
6 Key Companies Profiled 69
6.1 WINSUN 69
6.1.1 WINSUN Company Information 69
6.1.2 WINSUN Description and Business Overview 69
6.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 70
6.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio 71
6.2 Boehringer Ingelheim 71
6.2.1 Boehringer Ingelheim Company Information 72
6.2.2 Boehringer Ingelheim Description and Business Overview 72
6.2.3 Boehringer Ingelheim Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 73
6.2.4 Boehringer Ingelheim Classical Swine Fever Vaccines Product Portfolio 73
6.3 CAHIC 74
6.3.1 CAHIC Company Information 75
6.3.2 CAHIC Description and Business Overview 75
6.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 76
6.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio 76
6.4 SPAH 77
6.4.1 SPAH Company Information 78
6.4.2 SPAH Description and Business Overview 78
6.4.3 SPAH Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 79
6.4.4 SPAH Classical Swine Fever Vaccines Product Portfolio 79
6.5 Merck 80
6.5.1 Merck Company Information 80
6.5.2 Merck Description and Business Overview 81
6.5.3 Merck Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 82
6.5.4 Merck Classical Swine Fever Vaccines Product Portfolio 82
6.6 Ceva 82
6.6.1 Ceva Company Information 83
6.6.2 Ceva Description and Business Overview 83
6.6.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 84
6.6.4 Ceva Classical Swine Fever Vaccines Product Portfolio 84
6.7 Harbin Veterinary Research Institute 85
6.7.1 Harbin Veterinary Research Institute Company Information 85
6.7.2 Harbin Veterinary Research Institute Description and Business Overview 86
6.7.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 87
6.7.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio 87
6.8 Qilu Animal Health Products Factory 88
6.8.1 Qilu Animal Health Products Factory Company Information 88
6.8.2 Qilu Animal Health Products Factory Description and Business Overview 88
6.8.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 89
6.8.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio 89
6.9 Ringpu Biology 90
6.9.1 Ringpu Biology Company Information 90
6.9.2 Ringpu Biology Description and Business Overview 90
6.9.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 91
6.9.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio 92
6.10 DHN 92
6.10.1 DHN Company Information 92
6.10.2 DHN Description and Business Overview 93
6.10.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 94
6.10.4 DHN Classical Swine Fever Vaccines Product Portfolio 94
6.11 CAVAC 95
6.11.1 CAVAC Company Information 95
6.11.2 CAVAC Description and Business Overview 96
6.11.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 97
6.11.4 CAVAC Classical Swine Fever Vaccines Product Portfolio 97
6.12 Komipharm 98
6.12.1 Komipharm Company Information 98
6.12.2 Komipharm Description and Business Overview 99
6.12.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 99
6.12.4 Komipharm Classical Swine Fever Vaccines Product Portfolio 100
6.13 Agrovet 100
6.13.1 Agrovet Company Information 101
6.13.2 Agrovet Description and Business Overview 101
6.13.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 102
6.13.4 Agrovet Classical Swine Fever Vaccines Product Portfolio 103
6.14 Bioveta 103
6.14.1 Bioveta Company Information 103
6.14.2 Bioveta Description and Business Overview 104
6.14.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 104
6.14.4 Bioveta Classical Swine Fever Vaccines Product Portfolio 105
6.15 Jinyu Bio-Technology 105
6.15.1 Jinyu Bio-Technology Company Information 105
6.15.2 Jinyu Bio-Technology Description and Business Overview 106
6.15.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 106
6.15.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio 107
6.16 Institutul Pasteur 107
6.16.1 Institutul Pasteur Company Information 107
6.16.2 Institutul Pasteur Description and Business Overview 108
6.16.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 109
6.16.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio 109
6.17 MVP 110
6.17.1 MVP Company Information 110
6.17.2 MVP Description and Business Overview 110
6.17.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 111
6.17.4 MVP Classical Swine Fever Vaccines Product Portfolio 111
6.18 Tecon 111
6.18.1 Tecon Company Information 112
6.18.2 Tecon Description and Business Overview 112
6.18.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 113
6.18.4 Tecon Classical Swine Fever Vaccines Product Portfolio 113
7 Industry Chain and Sales Channels Analysis 114
7.1 Classical Swine Fever Vaccines Industry Chain Analysis 114
7.2 Classical Swine Fever Vaccines Key Raw Materials 115
7.2.1 Key Raw Materials 115
7.2.2 Raw Materials Key Suppliers 115
7.3 Classical Swine Fever Vaccines Production Mode & Process 117
7.4 Classical Swine Fever Vaccines Sales and Marketing 118
7.4.1 Classical Swine Fever Vaccines Sales Channels 118
7.4.2 Classical Swine Fever Vaccines Distributors 119
7.5 Classical Swine Fever Vaccines Customers 121
8 Classical Swine Fever Vaccines Market Dynamics 124
8.1 Classical Swine Fever Vaccines Industry Trends 124
8.2 Classical Swine Fever Vaccines Market Drivers 125
8.3 Classical Swine Fever Vaccines Market Challenges 126
8.4 Classical Swine Fever Vaccines Market Restraints 126
9 Research Findings and Conclusion 127
10 Methodology and Data Source 129
10.1 Methodology/Research Approach 129
10.1.1 Research Programs/Design 129
10.1.2 Market Size Estimation 130
10.1.3 Market Breakdown and Data Triangulation 131
10.2 Data Source 132
10.2.1 Secondary Sources 132
10.2.2 Primary Sources 133
10.3 Author List 135
10.4 Disclaimer 138
List of Tables
Table 1. Global Classical Swine Fever Vaccines Market Value Comparison by Source (2023-2029) & (US$ Million) 2
Table 2. Global Classical Swine Fever Vaccines Market Value by Sales Channel (2023-2029) & (US$ Million) 5
Table 3. Global Classical Swine Fever Vaccines Market Competitive Situation by Manufacturers in 2022 14
Table 4. Global Classical Swine Fever Vaccines Sales (M Doses) of Key Manufacturers (2019-2023) 15
Table 5. Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2019-2023) 16
Table 6. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Manufacturers (2019-2023) 18
Table 7. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers (2019-2023) 18
Table 8. Global Market Classical Swine Fever Vaccines Average Price (US$/K Doses) of Key Manufacturers (2019-2023) 21
Table 9. Global Key Players of Classical Swine Fever Vaccines, Industry Ranking, 2021 VS 2022 22
Table 10. Global Key Manufacturers of Classical Swine Fever Vaccines, Area Served & Headquarters 23
Table 11. Global Key Manufacturers of Classical Swine Fever Vaccines, Product Type & Application 24
Table 12. Founded Data of Global Key Classical Swine Fever Vaccines Manufacturers 25
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) 26
Table 14. Global Classical Swine Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Classical Swine Fever Vaccines as of 2022) 28
Table 15. Global Classical Swine Fever Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 30
Table 16. Global Classical Swine Fever Vaccines Sales by Region (2018-2023) & (M Doses) 31
Table 17. Global Classical Swine Fever Vaccines Sales Market Share by Region (2018-2023) 32
Table 18. Global Classical Swine Fever Vaccines Sales by Region (2024-2029) & (M Doses) 32
Table 19. Global Classical Swine Fever Vaccines Sales Market Share by Region (2024-2029) 32
Table 20. Global Classical Swine Fever Vaccines Revenue by Region (2018-2023) & (US$ Million) 33
Table 21. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2018-2023) 33
Table 22. Global Classical Swine Fever Vaccines Revenue by Region (2024-2029) & (US$ Million) 33
Table 23. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2024-2029) 34
Table 24. North America Classical Swine Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) 34
Table 25. North America Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses) 35
Table 26. North America Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses) 35
Table 27. North America Classical Swine Fever Vaccines Revenue by Country (2018-2023) & (US$ Million) 36
Table 28. North America Classical Swine Fever Vaccines Revenue by Country (2024-2029) & (US$ Million) 36
Table 29. Europe Classical Swine Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) 39
Table 30. Europe Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses) 40
Table 31. Europe Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses) 40
Table 32. Europe Classical Swine Fever Vaccines Revenue by Country (2018-2023) & (US$ Million) 41
Table 33. Europe Classical Swine Fever Vaccines Revenue by Country (2024-2029) & (US$ Million) 41
Table 34. Asia Pacific Classical Swine Fever Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) 45
Table 35. Asia Pacific Classical Swine Fever Vaccines Sales by Region (2018-2023) & (M Doses) 46
Table 36. Asia Pacific Classical Swine Fever Vaccines Sales by Region (2024-2029) & (M Doses) 46
Table 37. Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2018-2023) & (US$ Million) 47
Table 38. Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2024-2029) & (US$ Million) 48
Table 39. South America Classical Swine Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) 52
Table 40. South America Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses) 52
Table 41. South America Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses) 52
Table 42. South America Classical Swine Fever Vaccines Revenue by Country (2018-2023) & (US$ Million) 53
Table 43. South America Classical Swine Fever Vaccines Revenue by Country (2024-2029) & (US$ Million) 53
Table 44. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) 54
Table 45. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses) 55
Table 46. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses) 55
Table 47. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2018-2023) & (US$ Million) 56
Table 48. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2024-2029) & (US$ Million) 56
Table 49. Global Classical Swine Fever Vaccines Sales (M Doses) by Source (2018-2023) 59
Table 50. Global Classical Swine Fever Vaccines Sales (M Doses) by Source (2024-2029) 59
Table 51. Global Classical Swine Fever Vaccines Sales Market Share by Source (2018-2023) 59
Table 52. Global Classical Swine Fever Vaccines Sales Market Share by Source (2024-2029) 60
Table 53. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Source (2018-2023) 61
Table 54. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Source (2024-2029) 61
Table 55. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2018-2023) 61
Table 56. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2024-2029) 62
Table 57. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Source (2018-2023) 62
Table 58. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Source (2024-2029) 63
Table 59. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2018-2023) 64
Table 60. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2024-2029) 64
Table 61. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2018-2023) 64
Table 62. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2024-2029) 65
Table 63. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Sales Channel (2018-2023) 66
Table 64. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Sales Channel (2024-2029) 66
Table 65. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2018-2023) 66
Table 66. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2024-2029) 67
Table 67. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Sales Channel (2018-2023) 68
Table 68. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Sales Channel (2024-2029) 68
Table 69. WINSUN Company Information 69
Table 70. WINSUN Description and Business Overview 69
Table 71. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 70
Table 72. WINSUN Classical Swine Fever Vaccines Product 71
Table 73. Boehringer Ingelheim Company Information 72
Table 74. Boehringer Ingelheim Description and Business Overview 72
Table 75. Boehringer Ingelheim Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 73
Table 76. Boehringer Ingelheim Classical Swine Fever Vaccines Product 73
Table 77. CAHIC Company Information 75
Table 78. CAHIC Description and Business Overview 75
Table 79. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 76
Table 80. CAHIC Classical Swine Fever Vaccines Product 76
Table 81. SPAH Company Information 78
Table 82. SPAH Description and Business Overview 78
Table 83. SPAH Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 79
Table 84. SPAH Classical Swine Fever Vaccines Product 79
Table 85. Merck Company Information 80
Table 86. Merck Description and Business Overview 81
Table 87. Merck Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 82
Table 88. Merck Classical Swine Fever Vaccines Product 82
Table 89. Ceva Company Information 83
Table 90. Ceva Description and Business Overview 83
Table 91. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 84
Table 92. Ceva Classical Swine Fever Vaccines Product 84
Table 93. Harbin Veterinary Research Institute Company Information 85
Table 94. Harbin Veterinary Research Institute Description and Business Overview 86
Table 95. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 87
Table 96. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product 87
Table 97. Qilu Animal Health Products Factory Company Information 88
Table 98. Qilu Animal Health Products Factory Description and Business Overview 88
Table 99. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 89
Table 100. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product 89
Table 101. Ringpu Biology Company Information 90
Table 102. Ringpu Biology Description and Business Overview 90
Table 103. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 91
Table 104. Ringpu Biology Classical Swine Fever Vaccines Product 92
Table 105. DHN Company Information 92
Table 106. DHN Description and Business Overview 93
Table 107. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 94
Table 108. DHN Classical Swine Fever Vaccines Product 94
Table 109. CAVAC Company Information 95
Table 110. CAVAC Description and Business Overview 96
Table 111. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 97
Table 112. CAVAC Classical Swine Fever Vaccines Product 97
Table 113. Komipharm Company Information 98
Table 114. Komipharm Description and Business Overview 99
Table 115. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 99
Table 116. Komipharm Classical Swine Fever Vaccines Product 100
Table 117. Agrovet Company Information 101
Table 118. Agrovet Description and Business Overview 101
Table 119. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 102
Table 120. Agrovet Classical Swine Fever Vaccines Product 103
Table 121. Bioveta Company Information 103
Table 122. Bioveta Description and Business Overview 104
Table 123. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 104
Table 124. Bioveta Classical Swine Fever Vaccines Product 105
Table 125. Jinyu Bio-Technology Company Information 105
Table 126. Jinyu Bio-Technology Description and Business Overview 106
Table 127. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 106
Table 128. Jinyu Bio-Technology Classical Swine Fever Vaccines Product 107
Table 129. Institutul Pasteur Company Information 107
Table 130. Institutul Pasteur Description and Business Overview 108
Table 131. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 109
Table 132. Institutul Pasteur Classical Swine Fever Vaccines Product 109
Table 133. MVP Company Information 110
Table 134. MVP Description and Business Overview 110
Table 135. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 111
Table 136. MVP Classical Swine Fever Vaccines Product 111
Table 137. Tecon Company Information 112
Table 138. Tecon Description and Business Overview 112
Table 139. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023) 113
Table 140. Tecon Classical Swine Fever Vaccines Product 113
Table 141. Key Raw Materials Lists 115
Table 142. Raw Materials Key Suppliers Lists 115
Table 143. Classical Swine Fever Vaccines Distributors List 119
Table 144. Classical Swine Fever Vaccines Customers List 121
Table 145. Classical Swine Fever Vaccines Market Trends 124
Table 146. Classical Swine Fever Vaccines Market Drivers 125
Table 147. Classical Swine Fever Vaccines Market Challenges 126
Table 148. Classical Swine Fever Vaccines Market Restraints 126
Table 149. Research Programs/Design for This Report 129
Table 150. Key Data Information from Secondary Sources 133
Table 151. Key Data Information from Primary Sources 134
Table 152. Authors List of This Report 135
Table 153. QYR Business Unit and Senior & Team Lead Analysts 136
List of Figures
Figure 1. Product Picture of Classical Swine Fever Vaccines 1
Figure 2. Global Classical Swine Fever Vaccines Market Value Comparison by Source (2023-2029) & (US$ Million) 2
Figure 3. Global Classical Swine Fever Vaccines Market Share by Source: 2022 3
Figure 4. Global Classical Swine Fever Vaccines Market Share by Source: 2029 3
Figure 5. Tissue Culture Origin Product Picture 4
Figure 6. Cell Line Origin Product Picture 4
Figure 7. Global Classical Swine Fever Vaccines Market Value by Sales Channel (2023-2029) & (US$ Million) 6
Figure 8. Global Classical Swine Fever Vaccines Market Share by Sales Channel: 2022 7
Figure 9. Global Classical Swine Fever Vaccines Market Share by Sales Channel: 2029 7
Figure 10. Global Classical Swine Fever Vaccines Revenue, (US$ Million), 2018 VS 2023 VS 2029 9
Figure 11. Global Classical Swine Fever Vaccines Market Size (2018-2029) & (US$ Million) 9
Figure 12. Global Classical Swine Fever Vaccines Sales (2018-2029) & (M Doses) 10
Figure 13. Global Classical Swine Fever Vaccines Average Price (US$/K Doses) & (2018-2029) 11
Figure 14. Classical Swine Fever Vaccines Report Years Considered 12
Figure 15. Classical Swine Fever Vaccines Sales Share by Manufacturers in 2022 17
Figure 16. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers in 2022 20
Figure 17. Global 5 Largest Classical Swine Fever Vaccines Players: Market Share by Revenue in Classical Swine Fever Vaccines in 2022 27
Figure 18. Global 10 Largest Classical Swine Fever Vaccines Players: Market Share by Revenue in Classical Swine Fever Vaccines in 2022 28
Figure 19. Global Classical Swine Fever Vaccines Market Size by Region (US$ Million): 2018-2029 31
Figure 20. North America Classical Swine Fever Vaccines Sales Market Share by Country (2018-2029) 36
Figure 21. North America Classical Swine Fever Vaccines Revenue Market Share by Country (2018-2029) 37
Figure 22. U.S. Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 38
Figure 23. Canada Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 38
Figure 24. Mexico Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 39
Figure 25. Europe Classical Swine Fever Vaccines Sales Market Share by Country (2018-2029) 41
Figure 26. Europe Classical Swine Fever Vaccines Revenue Market Share by Country (2018-2029) 42
Figure 27. Germany Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 43
Figure 28. France Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 43
Figure 29. U.K. Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 44
Figure 30. Italy Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 44
Figure 31. Russia Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 45
Figure 32. Asia Pacific Classical Swine Fever Vaccines Sales Market Share by Region (2018-2029) 47
Figure 33. Asia Pacific Classical Swine Fever Vaccines Revenue Market Share by Region (2018-2029) 48
Figure 34. China Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 49
Figure 35. Japan Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 49
Figure 36. South Korea Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 50
Figure 37. India Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 50
Figure 38. Australia Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 51
Figure 39. Southeast Asia Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 51
Figure 40. South America Classical Swine Fever Vaccines Sales Market Share by Country (2018-2029) 53
Figure 41. Brazil Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 54
Figure 42. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share by Country (2018-2029) 56
Figure 43. Middle East and Africa Classical Swine Fever Vaccines Revenue Market Share by Country (2018-2029) 57
Figure 44. Middle East Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 57
Figure 45. Africa Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million) 58
Figure 46. Global Sales Market Share of Classical Swine Fever Vaccines by Source (2018-2029) 60
Figure 47. Global Revenue Market Share of Classical Swine Fever Vaccines by Source (2018-2029) 62
Figure 48. Global Sales Market Share of Classical Swine Fever Vaccines by Sales Channel (2018-2029) 65
Figure 49. Global Revenue Market Share of Classical Swine Fever Vaccines by Sales Channel (2018-2029) 67
Figure 50. Classical Swine Fever Vaccines Value Chain 114
Figure 51. Classical Swine Fever Vaccines Production Process 117
Figure 52. Channels of Distribution 118
Figure 53. Distributors Profiles 121
Figure 54. Bottom-up and Top-down Approaches for This Report 131
Figure 55. Data Triangulation 132
Figure 56. Key Executives Interviewed 134

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs